{"id":447906,"title":"Consultation on the Prescription Drug List: Hydroquinone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:34:30.222000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html?wbdisable=false","snippet":"Consultation on the Prescription Drug List: Hydroquinone The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products.…","rawSnapshotUrl":"/api/snapshots/raw/447906","browseUrl":"https://replay.healtharchive.ca/job-6/20260103153430/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-prescription-drug-list-hydroquinone.html?wbdisable=false#ha_snapshot=447906","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}